Want to see SE:CLBIO full AI Analyst Report?
Corline Biomedical AB (CLBIO) Revenue
Corline Biomedical AB Revenue
Corline Biomedical AB had a revenue of 4.69M in the quarter ending Jun 30, 2026, with 9.23%. This bring the company's revenue in the last twelve months to 12.39M, Increased 25.29%. In the fiscal year ending Dec 31, 2025, Corline Biomedical AB had annual revenue of 7.65M with -21.73% growth.
- Revenue (ttm)
- 12.39M
- Revenue Growth
- 54.37%
- P/S Ratio
- 48.50
- Revenue/Employee
- SEK 546,500
- Employees
- 14
- Market Cap
- SEK 371.09M
Revenue Chart
Corline Biomedical AB Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.65M | -2.12M | -21.73% |
| Dec 31, 2024 | 9.78M | -15.26M | -60.95% |
| Dec 31, 2023 | 25.03M | 1.48M | 6.28% |
| Dec 31, 2022 | 23.55M | 16.49M | 233.47% |
| Dec 31, 2021 | 7.06M | 3.37M | 91.07% |
| Dec 31, 2020 | 3.70M | 2.63M | 247.37% |
| Dec 31, 2019 | 1.06M | -499.00K | -31.93% |
| Dec 31, 2018 | 1.56M | 925.00K | 144.98% |
| Dec 31, 2017 | 638.00K | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.